Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-05-30

Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer

View source ↗

Summary

An observational study evaluating Avastin (bevacizumab) in patients with ovarian cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ovarian Cancer | Status: COMPLETED